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Abstract.  In order for secretion to progress, ER- 
derived transport vesicles must target to, and fuse with 
the cis-Golgi compartment. These processes have been 
reconstituted using highly enriched membrane frac- 
tions and partially purified soluble components. The 
functionally active yeast Golgi membranes that have 
been purified are highly enriched in the cis-Golgi 
marker enzymes al,6 mannosyltransferase and GDP- 
ase. Fusion of transport vesicles with these membranes 
requires both GTP and ATP hydrolysis, and depends 
on cytosolic and peripheral membrane proteins. At 
least two protein fractions from yeast cytosol are re- 
quired for the reconstitution of ER-derived vesicle fu- 
sion. Soluble fractions prepared from temperature-sen- 
sitive mutants revealed requirements for the Yptlp, 
Secl9p, Slylp, Sec7p, and Usol proteins. A model for 
the sequential involvement of these components in the 
targeting and fusion reaction is proposed. 
T 
RANSPORT of proteins  between membrane-bound 
compartments of the secretory pathway is a process 
common to  all  eucaryotic cells. Transport  is  be- 
lieved to involve the production of coated vesicle interme- 
diates from a donor compartment and the subsequent un- 
coating, targeting, and fusion of these  vesicles  with an 
acceptor compartment (for reviews see Pryer et al., 1992; 
Rothman and Orci,  1992; Barlowe et al., 1994). The gen- 
eral mechanism of vesicle budding, targeting and fusion 
and the principal  protein players involved in these reac- 
tions appears to be conserved from yeast to human cells 
(for review see Rothman, 1994). 
We have developed a cell-free assay that measures the 
transit of the soluble precursor of the yeast mating phero- 
mone et factor from the ER to the cis-compartment  of the 
Golgi apparatus  in yeast (Rexach and Schekman, 1991; 
Wuestehube and Schekman, 1992). The nucleotide and 
protein  requirements for the production of ER-derived 
vesicles, as well as the polypeptide composition of purified 
vesicle intermediates have recently been characterized in 
detail (Barlowe et al., 1994; Rexach et al., 1994). Sec pro- 
teins act upon ER membranes to form transport vesicles 
shaped by cytoplasmic coat molecules consisting of Sarlp, 
Secl3p, Sec23p, Sec24p, and Sec31p. Vesicles formed un- 
der these conditions contain a specific set of lumenal and 
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membrane  proteins  that  include  core-glycosylated  pro- 
a-factor, Betlp, Sec22p, and Boslp, but are depleted of 
ER-resident proteins Kar2p,  Secl2p, and Sec61p. Trans- 
port vesicles derived from the ER rapidly fuse with the 
cis-Golgi via a vesicle targeting mechanism that is appar- 
ently both selective and efficient. The soluble N-ethylmale- 
imide-sensitive fusion  (NSF)  1 attachment protein (SNAP) 
receptor (SNARE) hypothesis was postulated to explain 
this  selective  targeting  (S61lner et  al.,  1993; Rothman, 
1994). According to this hypothesis all  eukaryotic cells 
have families of organelle-specific  receptor molecules (v- 
and t-SNAREs) whose members form highly specific pairs 
that are essential for vesicle docking. ER-derived vesicles 
carry an ER v-SNARE, which presumably has a cognate 
t-SNARE  on cis-Golgi membranes.  Furthermore,  after 
vesicle targeting mediated by the v/t-SNARE mechanism 
is achieved, additional cytosolic proteins such as NSF-like 
and SNAP-like proteins bind to the SNARE complex and 
facilitate the membrane fusion process. 
The details of the proteins involved in targeting and fu- 
sion of transport vesicles with the Golgi apparatus, as well 
as when and how they act, are poorly understood. Yeast 
offers a powerful system for addressing these questions, 
especially since the purified ER-derived vesicles described 
above are competent for fusion with cis-Golgi membranes 
(Rexach et al.,  1994). Through a  combined genetic and 
1. Abbreviations used in this paper: CPY, carboxypeptidase;  LSF, low salt 
fraction; HSF, high salt fraction; MSS, medium speed supernatant;  NSF, 
N-ethylmaleimide-sensitive  fusion  protein;  PGK,  phosphoglycerate  ki- 
nase; SNAP, soluble NSF attachment protein; SNARE, SNAP receptor. 
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been  identified that  appear  to  be  involved in  the  late 
stages of ER-to-Golgi transport. Four of these are mem- 
brane proteins; three corresponding to ER v-SNARE-like 
molecules (Sec22p, Betlp, Boslp); and the fourth a Golgi 
t-SNARE-like  molecule  (Sed5p).  Also  involved  are  a 
number of soluble  and/or peripheral membrane proteins: 
Sec7p, Sec17p (the yeast a-SNAP homolog), Sec18p (an 
NSF homolog), Sec19p, Yptlp  (small  GTP-binding pro- 
tein), Slylp, Usolp (yeast homolog of mammalian trans- 
port factor p115), and the yeast coatomer complex. 
In this report we describe  an adaptation of our in vitro 
system to study the targeting and fusion of ER-derived 
vesicles with the Golgi apparatus. Functional yeast Golgi 
membranes as well as ER-derived transport vesicles were 
purified.  We find that ER-derived vesicles can fuse with 
the Golgi complex with high efficiency in the presence of 
ATP,  GTP  and  soluble  fractions  enriched  for  Sec7p, 
Yptlp, Slylp, and Usolp. ATP- and GTP-hydrolysis are 
required for the fusion process  to occur.  We have used 
two-stage  incubations and the selective  inhibitory effects 
of  ATP~/S, GTP~/S, and  cytosol  prepared  from  yeast 
strains harboring specific temperature-sensitive mutations 
to study the biochemical order of involvement of different 
proteins  in the  targeting/fusion process.  The  sequential 
steps operationally defined by these reagents are likely to 
reflect transport intermediates in vesicle recognition, for- 
mation of a docking complex, and fusion. 
Materials and Methods 
Materials 
The Saccharomyces  cerevisiae strains used in these experiments are listed 
in Table I. Strains were grown in YPD medium containing 1% Bacto yeast 
extract, 2% Bacto peptone (Difco Laboratories Inc., Detroit, MI) and 2% 
glucose. Other reagents were obtained as described by Baker et al. (1990). 
Antibodies used were directed against Ochlp (Nakayama et al., 1992), 
Sec7p (Franzusoff et al., 1992),  Sec12p (Barlowe and Sehekman, 1993), 
Secl7p (Griff et al., 1992), Secl8p (Eakle et al., 1988), Betlp (Rexaeh et 
al., 1994), Mnnlp (Graham et ai., 1994), Kex2p (Fuller et al., 1989), Sed5p 
(Hardwick and Pelham, 1992), Yptlp (Segev et al., 1988), Slylp (Dascher 
et al., 1991), GDPase (Abeijon et al., 1989), Arflp (kindly provided by R. 
Table L Yeast Strains Used in This Study 
Strain  Genotype 
RSY271 
RSY298 
RSY300 
RSY448 
RSY607 
RSY610 
RSY919 
RSY942 
RSY944 
RSY946 
RSY948 
RSY949 
RSY950 
RSY951 
RSY954 
RSY976 
RSY1074 
MATs his4-619 ura3-52 sec  18-1 
MATa ade2 his3-11,15  1eu2-3,112 trpl-1 ura3-1 sec7-1 
MATer his3-11,15  leu2-3,112  tura3-1 see7-4 
MATa his3-11,15  leu2-3,112 trpl-1 PEP4::URA3 secl7-1 
MATs leu2-3,112  ura3-52 PEP4::URA3 
MATtx his3-11,15  ura3-1 PEP4::URA3 secl9-1 
MATs ura3-1 mnnl mnn2 
MATa lys2-801 his4-619 sec22-3 
MATa lys2-801 ura3-52 betl- 1 
MATa lys2-801 bet 2-1 
MATa lys2-801 trpl-1 ura3-52 usol-1 
MATer lys2-801 trpl-1 ura3-52 usol-1 
MATa his3-11,15  leu2-3,112  ura3-1 YPT1 ::yptPSLEU2 
MATer his3-11,15  leu2-3,112  YPTI::yptlt~LEU2 
MATa lys2-801 leu2-3,112 sec32-1 
MATa ura3-52 yptl-3 
MATer ade2-1 leu2-3,112  trpl-1 ura3-1 slyl  ts 
Kahn), Sec21p (Hosobuchi et al., 1992), Sec61p (Sterling et al., 1992), and 
Sec23p (Hicke and Schekman, 1989). Standard methods for yeast genetic 
manipulations (Sherman et al., 1974), SDS-PAGE (Laemmli, 1970), im- 
munoblotting (Towbin et al., 1979),  and immunodetection by enhanced 
chemiluminescence (Amersham Corp., Arlington Heights, IL) were used. 
Deuterium oxide, Nycodenz, GTP, GDP, GTPTS, and ATP~tS were pur- 
chased from Sigma Chemical Co. (St. Louis, MO). 
Purification  of Golgi-enriched Membranes 
RSY919 cells were grown at 25°C in 11 YPD medium to early exponential 
phase (OD~00 about 1). Ceils (1,200 ODr00 units) were harvested by cen- 
trifugation and washed twice with buffer A  (20 mM Hepes, pH 6.5, 150 
mM KOAc, 250 mM sorbitol). All subsequent steps were performed at 
4°C.  Cell pellets were resuspended in a  Corex 30-ml glass tube in 3 ml 
buffer A containing I mM DTT, 1 mM ATP, 0.1 mM MnCl2 and 10 p.l of a 
proteinase inhibitor cocktail ( pepstatin, aprotinin, leupeptin, antipain (1 
mg/ml each), 100 mM phenylmethylsulphonyl fluoride, and 100 mM benz- 
amidine). Glass beads (4 g) were added and cells were lysed by 4 l-rain peri- 
ods of agitation in a  VWR vortex at full speed. The homogenate was 
cleared by centrifugation at 500 g for 5 rain. The supernatant fraction was 
subjected to 10,000 g for 10 min to yield a postmitochondrial superuatant 
fraction, $10,  which was then centrifuged at  50,000  g  for 15  min  in a 
TLA100.3 rotor (Beckman Instruments, Inc.) to yield a pellet, P50, and a 
superuatant, $50.  The $50 fraction was loaded on top of a sucrose step 
gradient made in buffer B  (20 mM Hepes, pH 6.5, 1 mM ATP in D20), 
consisting of I m160% sucrose (wt/wt), 3 m120% sucrose (wt/wt), and 3 ml 
7% sucrose. The gradient was centrifuged for 2 h at 150,000 g in a SW41 
rotor (Beckman Instruments, Inc., Palo Alto, CA). Membranes were col- 
lected from the sample/.7% sucrose interface (fraction B1), the 7%/20% 
sucrose interface (fraction B2), and the 20%/60% sucrose interface (frac- 
tion B3).  Fraction B2,  containing the main portion of c/s-Golgi mem- 
branes, was mixed with I ml of 60% sucrose in D20, placed in a centrifuge 
tube, and overlaid with I ml each of 30, 25, and 10% sucrose in D20. This 
gradient was centrifuged for 3 h at 150,000 g in a SW55 rotor (Beckman 
Instruments, Inc.). Golgi enriched membranes (fraction FB2) were col- 
lected from the interface between the 10%  and 25% sucrose layers and 
frozen in liquid nitrogen in 100-1~1 aliquots for storage at -80°C. 
Preparation of  Membrane-free Cytosol and ER-derived 
Transport  Vesicles 
Membrane-free cytosol was prepared as described previously (Rexach 
and Schekman, 1991) with some modifications. A  postmitochondrial su- 
peruatant was prepared by centrifugation of a cleared total homogenate at 
100,000 g for 30 rain. An equal volume of 60% Nycodenz (Sigma Chemi- 
cal Co.) in buffer B was added, and the mixture (3 ml) was loaded in a 5 ml 
centrifuge tube (SW55 rotor) and overlaid with 1 ml of 30% Nycodenz in 
buffer B  followed by  1 ml  buffer B.  The gradient was centrifuged at 
100,000 g for 3 h to allow light membranes to float. Membrane-free cyto- 
sol (2.8 ml) was collected from the bottom of the tube and desalted by fil- 
tration on a Sephadex G25 column (15 ml) equilibrated in B88 (Baker et 
al., 1988) containing i  mM ATP. The eluted protein peak was pooled and 
100-pJ aliquots were frozen in liquid nitrogen for storage at -80°C. The 
preparation of ER-enriched microsomal membranes and the loading of 
these membranes with [3SS]methionine-labeled prepro-ct-factor  by in vitro 
translocation has been described by Wuestehube and Schekman (1992). 
ER-derived vesicles were purified either from a Yptlp-dependent trans- 
port reaction (Rexach et al.,  1994) or from a vesicle formation reaction 
utilizing purified protein components ( Barlowe et at., 1994). In the latter 
case the reaction mixture contained 100 p,l washed microsomes (120  p.g 
protein), an ATP regenerating system (Baker et al., 1988), 0.1 mM GTP, 
Sarlp (3 p~g), Sec23/Sec24p complex (20 p~g), and Sec13/Sec31p complex 
(5 p,g) in a total volume of 600 p,l. Reactions were incubated for 30 rain at 
30°C. A medium speed supernatant (MSS) fraction, prepared by centrifu- 
gation for 5  min at  13,000  g  in a  TOMY  refrigerated microcentrifuge 
(Tomy Seiko, Tokyo, Japan) at 4°C, was mixed with 500 p.150% Nycodenz 
in D20  (wt/wt) and placed on the bottom of a  2.3  ml centrifuge tube 
(TLS55 rotor). A discontinuous gradient was prepared by overlaying the 
sample with 0.5 ml each of 27 and 10% sucrose in D20/buffer88. The gra- 
dient was centrifuged for 4 h at 150,000 g. Floated vesicles (300 ixl) were 
collected at the 27/10% sucrose interface and frozen in liquid nitrogen in 
100-1xl aliquots for storage at -80°C. Vesicle release was quantified by de- 
termining the amount of protease-protected, Con A-precipitable [3aS]gp- 
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1991). 
In Vitro Targeting  and Fusion of  ER-derived Vesicles 
with Golgi  Membranes 
Vesicle chase reactions were performed using floated ER-derived vesicles, 
containing a cargo of core-glycosylated [3SS]methionine-labeled  pro-~-fac- 
tor, as donor membranes. Vesicles (5 p,1)  were mixed on ice with 0.8 p,g of 
Golgi membranes, 60 p,g cytosolic protein, an ATP regeneration system 
(Baker et al., 1988) and 0.5 mM GTP in a total volume of 30 Ixl and incu- 
bated for 60 min at 20°C. After incubation the mixture was processed for 
anti-cd,6-mannose immunoprecipitation or for Con A-Sepharose precipi- 
tation  (Rexach and Schekman, 1991).  The percentage of transport was 
calculated as the anti-ul,6-mannose immunoprecipitable c.p.m, divided by 
the total Con A-Sepharose precipitable c.p.m, multiplied by 100. Other 
additions to reactions included: 1 Ixg per reaction anti-Yptlp Fab frag- 
ments, 1 p,g per reaction yeast Yptlp isolated from Escherichia coil (Baker 
et al.,  1990), 100 p~M GTPTS  +  1 mM GTP, 200 ixM GMPPNP _+  1 mM 
GTP, 1 mM ATP'/S, or 5 mM EGTA/600 p,M MnCI  2 -+ 500 I~M CaCI2. 
In "two stage" transport experiments vesicles and Golgi membranes 
were first incubated (20 min, 20°C)  in the presence of 60 p~g of cytosol, 
prepared from the cells of different mutant strains (stage 1). Then samples 
were chilled for 5 min before addition of 20 Ixg of wild type cytosol (with 
or without various inhibitors). Samples were then incubated for 40 min at 
20°C and processed as above. 
Enzyme Assays 
The  standard assay (20  p,l) for ct-l,6mannosyltransferase contained 0.1 
ixCi  GDP-[3H]mannose  (New  England  Nuclear,  Boston,  MA),  1  mM 
GDP-mannose, 1 mM ATP, 1 mM MnCI2, B88, and was initiated by addi- 
tion of membranes. After a  10-min incubation at 2&C, the reaction was 
stopped by the addition of 20 Ixl 2% SDS. The sample was then incubated 
for 5 rain at 100°C and processed for immunoprecipitation using anti-ed,6- 
mannose antibodies. The incorporation of [3H]mannose into ctl,6 manno- 
proteins was linear with respect to the incubation time (0-15 min) and 
membrane concentration (0.1-20 Ixg of protein). Enzyme activity is ex- 
pressed in cpm of [3H]mannose incorporated per rain and p,g protein. All 
other  enzymes  were  measured  using  standard  assays  for  guanosine 
diphosphatase (Abeijon et al., 1989), ct-mannosidase (Opheim, 1978), and 
cytochrome c  oxidase  (Mason  et  ai.,  1973),  vanadate-sensitive  Mg  2+- 
ATPase (Willsky, 1979). Total protein was measured with the Dc protein 
assay (Bio-Rad Laboratories, Richmond, CA) according to the manufac- 
turer's instructions. 
Electron Microscopy  and lmmunolocalization 
For routine electron microscopy, the sample fractions were pre-fixed with 
1%  glutaraldehyde, and then centrifuged to obtain pellets. The samples 
were fixed in 2% glutaraldehyde in cacodylate buffer, washed, post-fixed 
in 1% osmium tetroxide, followed by 0.5% tannic acid mirdant. En bloc 
staining with 2% uranyl acetate was done before ethanol dehydration and 
embedding in epoxy resin. Thin sections contrasted with uranyl acetate 
and lead citrate were viewed in the Philips 301 electron microscope. 
Samples for immunoelectronmicroscopy were fixed in 3%  formalde- 
hyde -  0.2% glutaraldehyde, washed, dehydrated, and embedded in Lon- 
don Resin White. Thin sections were incubated first with affinity-purified 
antibody to Yptlp, washed, and then incubated with goat anti-rabbit Fab 
fragments conjugated to 5 nm colloidal gold. As a control, similar sections 
were incubated without the primary antibody. 
Results 
Isolation of Golgi-enriched Membranes 
The first step in reconstruction of the targeting/fusion re- 
action involved obtaining highly enriched donor (ER vesi- 
cles) and acceptor (Golgi) membrane fractions. We devel- 
oped  a  method  for  the  rapid  isolation  of  yeast  Golgi 
membranes that are enriched for specific marker proteins 
and highly active as an acceptor compartment in our in 
vitro  transport  reaction.  As  a  marker  for  Golgi  mem- 
branes  we  used ,*l,6-mannosyltransferase activity (al,6- 
MT),  measured  by  incorporation  of  [3H]mannose  from 
GDP-[3H]mannose into the  outer chains of endogenous 
yeast glycoproteins. We found that lysates produced by 
glass bead agitation of intact yeast cells, rather than by ho- 
mogenization of yeast spheroplasts, produced a higher ac- 
tivity Golgi membrane fraction. We also found that func- 
tional Golgi membranes were labile; acceptor activity (see 
below) was lost with a half-time of 6 h  at 0°C. Therefore 
the purification was designed to be completed in one day 
so that Golgi membranes could be frozen in aliquots. Ac- 
ceptor  activity  remained  active  in  samples  stored  at 
-80°C. As diagrammed in Fig. 1 Golgi membranes were 
isolated from strain RSY919 which carries the mnnl  and 
mnn2  mutations.  This  mutant  has  wild-type  secretory 
properties, but does not contain etl,2- or al,3-mannosyl- 
transferases whose activity would interfere with the ed,6MT 
assay. Differential centrifugation of a total yeast lysate re- 
vealed that more than 80% of ctl,6MT activity was present 
in the $50 fraction (Fig. 2 a). After density centrifugation 
on a sucrose/D20 gradient the majority (65%) of al,6MT 
activity was found in the B2 fraction (Fig. 2 b). Most of this 
activity (95%)  floated in  a  sucrose gradient as  a  single 
peak (Fig. 2 c). 
Table II is a purification table for a typical Golgi mem- 
brane isolation. The specific activity of the Golgi marker 
enzyme  etl,6MT  increased  after  sedimentation  in  the 
sucroseD20 gradient 17-fold over the activity in the total 
cell lysate. Overall enrichment of al,6MT after flotation 
was 518-fold with a 19% yield. 
Biochemical and Morphological Characterization of 
Golgi-enriched Membrane Fraction 
We used biochemical and immuno electron-microscopical 
criteria to document the enrichment of Golgi membranes 
Figure 1.  Flow diagram for purification of yeast c/s-Golgi mem- 
branes. The general scheme used to isolate Golgi membranes is 
presented. Details are described in Materials and Methods. 
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Figure 2.  Purification  of al,6MT-containing membranes. (A) Crude yeast lysate was fractionated as in Materials and Methods and the 
amount of the 1,6MT activity in the original lysate and early fractions was determined. (B) $50 was loaded on top of a sucrose/D20 step 
gradient. Membranes were sedimented for 2 h at 150,000 g and 23x 0.4 ml fractions were collected from the top. Protein concentration 
(filled circles), enzyme activity (open circles), and sucrose concentration (dashed line) were measured in every fraction. The peak of 
1,6MT activity (fractions 13-16) was pooled. (C) The sample density was adjusted to 35% sucrose, loaded on the bottom of sucrose/D20 
step gradient, and membranes were floated for 3 h at 150,000 g. Fractions (11 x 0.5 ml) were collected from the top. The Golgi peak was 
pooled as before and analyzed. The arrows in the top x axis point to the direction of membrane movement during sedimentation and flo- 
tation. 
in  our preparations.  Characteristic  proteins  and  enzyme 
activities  are  associated  with  the  different  cellular  or- 
ganelles and may be used to assess the purity of fractions. 
The result  of marker protein  assays from a  typical frac- 
tionation are shown in Table III and Fig. 3. The markers 
used are as follows: cytochrome c oxidase as a marker for 
the inner membrane of mitochondria (Mason et al., 1973); 
Sec61p and Sec12p as ER markers; the membrane-bound 
enzyme  a-mannosidase  as  a  vacuole  marker  (Opheim, 
1978);  vanadate-sensitive  Mg2+-ATPase  as  an  integral 
membrane  protein  of  the  plasma  membrane  (Willsky, 
1979); and phosphoglycerate kinase (PGK) as a soluble cy- 
tosolic protein. As markers for the cis, medial- and trans- 
Golgi compartments we used the al,6MT structural protein 
(Ochlp),  GDPase,  al,3-mannosyltransferase  structural 
protein  (Mnnlp)  and  endoproteinase  Kex2p (Nakayama 
et al., 1992; Graham et al., 1994; Redding et al., 1991). The 
specific activities of cytochrome c oxidase, et-mannosidase, 
Mg2+-ATPase,  GDPase  and  ed,6MT  were  determined 
from enzyme and protein assays. Other proteins were de- 
tected by immunoblotting as indicated in Table III. 
Less than 1% of the total cell lysate content of the mark- 
ers for plasma membrane, ER, mitochondria, and cytosol 
were found in the  Golgi pool.  Markers for the  different 
Golgi  compartments  (Franzusoff  et  al.,  1989)  were  en- 
riched  to  different  extents:  Kex2p,  a  marker  for  trans- 
Golgi, was enriched 60-fold; Mnnlp, a marker for the me- 
Table II. al,6-Mannosyltransferase  Distribution during Golgi 
Purification 
ct 1,6-Mannosyltransferase 
Fraction  Total  protein  Total activity*  Specific activity  Fold  purification  Yield 
mg  % 
Lysate  200.1  46  231  1.0  100 
$50  170.2  42  251  1.1  92 
Pool 2  15.1  20  1,900  8.2  43 
FI. Golgi  0.09  11  130,000  562  25 
*  v  ctl,6-Mannosyltransferase acti ity is expressed  as cpm [3H]mannose  ×  10  3  incorpo- 
rated into mannoproteins  per minute. 
dial Golgi, was enriched 94-fold; and Ochlp, a marker for 
the cis-Golgi, was enriched more then 800-fold. Another 
Golgi marker, GDPase, was enriched  205-fold which  re- 
flects the broad distribution of this enzyme among differ- 
ent Golgi sub-compartments (Witters et al., 1994).  Among 
the tested peripheral membrane proteins we found greater 
than 30-fold enrichment for the small GTP-binding pro- 
tein,  Yptlp,  and  Secl7p  in  the  Golgi  pool  (data  not 
shown).  Detectable  amounts  of  Secl8p,  Sed5p,  Betlp, 
Stylp,  Sec7p,  Sec22p,  Boslp,  and  Sec21p  ('y-subunit  of 
yeast coatomer complex; Hosobuchi et al., 1992) were also 
found  to  be  tightly  associated  with  the  purified  mem- 
branes (Fig. 3). 
To assess the purity of the Golgi membranes morpho- 
logically, the  enriched  Golgi pool was examined by thin 
section  and  immunoelectron microscopy. Membranes  in 
the  Golgi-enriched  fraction  (Fig.  4,  a  and  b)  appeared 
mainly as an array of spherical to discoid vesicles and tu- 
bules, 50-300 nm in diameter or length. Most of the larger 
tubular structures  (arrowheads, Fig. 4 b) resemble cross- 
sectional views of Golgi cisternae as observed in the intact 
Table IlL Distribution of Marker Enzymes and Proteins in the 
Total Yeast Lysate and Enriched Golgi Fraction 
Lysale 
(specific  Golgi fraction 
Marker protein  OrganeUe  activity)  (fold enrichment) 
Ochlp*  cis-Golgi  0.14  112.5  804 
GDPase (units)  Golgi  0.47  96.3  205.1 
Mnnlp*  med-Golgi  7.0  655.6  93.6 
Sec 12p*  ER  29.3  64.5  2.2 
ct-Mannosidase  vacuole  1.4  8.4  5.9 
(milliunits) 
PM ATPase  PM  0.27  0.8  2.9 
(units) 
Cyt c oxidase  mitochondria  0.03  0.07  2.2 
(units) 
PGK*  cytosol  53.2  0.5  0.01 
*Aliquots of total lysate and enriched Golgi fractions were subjected to SDS-PAGE, 
and imrnunoblotted with different antibodies. Immuno-complexes  were detected by 
125I-protein A and quantified using a PhosphoImager. 
The Journal of Cell Biology, Volume 132, 1996  280 Figure 3.  Polypeptide and antigenic composition of c/s-Golgi en- 
riched  membranes.  Samples  of total  yeast  lysate  and  floated 
Golgi membranes  were solubilized in sample buffer and sepa- 
rated  on  an  SDS-polyacrylamide  (10%)  gel. The  right  panel 
shows the silver stain (equal protein amount loaded), and the left 
panel shows the blot immunostaining  for the different marker 
proteins (protein concentration in the total lysate sample was 10 
times higher than in the Golgi membrane sample). 
yeast cell (Preuss et al., 1992). Small fragments of Golgi 
membranes are not easily identified because they may be 
indistinguishable from other membrane vesicles especially 
if the lumen of these fragments dilates during the purifica- 
tion process. Since specific labeling of yeast Golgi mem- 
branes  by antibodies  to  Yptlp  has  been previously de- 
scribed  (Preuss et al.,  1992),  immunolocalization of this 
marker provided a  better assessment of the efficiency of 
our purification procedure. A significant fraction (43%) of 
the  membrane  profiles were  labeled  by affinity-purified 
antibodies to Yptlp (Fig. 4 d). Occasional linear arrays of 
gold  label  (small arrowheads,  Fig.  4  d)  suggest  staining 
over a cisternae-like structure. 
Enriched Membranes Reconstitute Sec 
Protein-dependent Targeting/Fusion 
Because our goal was to use isolated Golgi membranes for 
the identification and characterization of components that 
mediate ER-Golgi vesicular transport, we tested the spe- 
cific activity of enriched Golgi membranes in an in vitro 
transport assay. Specific activity was expressed as the abil- 
ity of Golgi membranes to allow purified ER-derived vesi- 
cles loaded with [3SS]glyco-pro-a-factor to target and fuse. 
After fusion  [35S]gp-a-factor acquires specific al,6-man- 
nose residues (Rexach and Schekman, 1991). We showed 
before that the isolated ER-derived transport vesicle frac- 
tion is devoid of ER marker proteins (Barlowe et al., 1994; 
Rexach et al.,  1994).  Furthermore, the transport vesicles 
fuse  with  cis-Golgi  membranes,  but  not  with  ER mem- 
branes. Thus, no new ER vesicles form, and the isolated 
Golgi  membranes  are  the  only  potential  target  in  the 
course of the fusion reaction. Conversion of the [35S]gp-a- 
factor contained in the vesicle fraction to the ed,6-man- 
nose modified form required the addition of both cytosol 
and  an  acceptor  membrane  fraction  (Fig.  5).  Minimal 
(<10%) vesicle chase was observed when cytosol or GTP 
was  omitted  from the  reaction.  Purified  Golgi-enriched 
membranes contained about 100 times more acceptor ac- 
tivity compared to total yeast membranes (maximum ac- 
tivity for the transport in 30 Ixl reaction required 0.8 ~g pu- 
rified  Golgi  membranes  and  about  80-100  Ixg  of  total 
membranes). The transport activity was linear with respect 
to the membrane concentration and about 30 ixg/ml Golgi 
membranes was sufficient to convert 47% of the [35S]gp- 
a-factor  to  the  outer-chain  modified  form  (data  not 
shown). We showed previously that a late stage in the total 
ER to Golgi transport reaction requires ATP hydrolysis 
and Ca  2+  (Rexach and Schekman, 1989). Transport with 
purified membrane components required GTP and ATP 
hydrolysis and was inhibited by 74% in the presence of 100 
p~M GTP~/S or 200 ~M GMPPNP and by 51% in the pres- 
ence of 2 mM ATP~/S (Fig. 6). As in an overall ER-Golgi 
transport reaction in the crude cell lysate the targeting/fu- 
sion reaction with enriched membranes was Ca2+-depen  - 
dent, and inhibited 80% by the chelators 5 mM EGTA or 
1 mM BAPTA. 
In  vitro targeting  and  fusion  of purified vesicles with 
Golgi membranes required the addition of yeast cytosol. 
We used our reconstituted system and temperature sensi- 
tive yeast mutants to determine the role of the different 
soluble  proteins  facilitating  targeting  and  fusion.  We 
found that cytosols prepared from sec7-1, sec7-4, sec18-1, 
usol-1, slyP  ~, sec19-1, yptl-3, and yptl ~ mutant cells grown 
at  permissive  (24°C)  temperature  supported  transport. 
However,  a  short  pre-incubation  of mutant  cytosols  at 
30°C  inactivated their ability to support transport (Fig. 7 
and  data  not shown).  Cytosols prepared from wild type 
cells or strains  defective in  ER-vesicle budding  (secl2-1 
and sec23-1)  did not show any defect before or after pre- 
incubation at elevated temperatures. Purified Golgi mem- 
branes  from secT-4,  sec18-1,  usol-1,  slyP  s,  sec19-1,  and 
yptl ~ mutant cells grown at the permissive (24°C) temper- 
ature had wild-type acceptor activity in the presence of cy- 
tosol and  donor vesicles prepared  from wild  type yeast 
(data  not  shown).  Unfortunately, pre-treatment  of wild 
type or mutant Golgi membranes at elevated temperature 
resulted in a  dramatic loss of acceptor activity. Inactiva- 
tion of Secl8p by NEM treatment was used before in the 
ER-Golgi in vitro transport reaction (Rexach and Schek- 
man,  1991).  However,  with  purified  Golgi  membranes 
such treatment resulted in a dramatic inactivation of gly- 
cosylation  machinery  (or  GDP-mannose  transport  sys- 
tem), as measured by incorporation of [3H]mannose from 
Lupashin et al. ER Vesicle Targeting and Fusion to Golgi Membranes  281 Figure 4.  Electron micrographs of enriched cis-Golgi membranes. (A) A representative view of the pooled Golgi fraction from the su- 
crose flotation gradient. (B) Higher magnification of the enriched Golgi membranes showing several cisternae resembling that seen in 
the intact yeast (arrowheads). (C) Control for immunolocalization of Yptlp where primary antibody was omitted and no gold label is 
seen. (D) Immunolocalization of Golgi marker, Yptlp, shows gold label on many membranes of the Golgi-enriched fraction. Small ar- 
rowheads note linear display of gold particles over cisternae-like structures. Bars: (A) 0.6 ixm; (B-D) 0.2 mm. 
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Figure 5.  Transport  reaction with purified donor  (ER-derived 
vesicles) and acceptor (cis-Golgi membranes) components. Ali- 
quots of floated transport vesicles (5 ~1) were mixed with fresh 
membrane-free cytosol (60 Ixg), purified Golgi membranes (0.8 
Ixg), an ATP regeneration mix, and 0.2 mM GTP as indicated. 
Samples were incubated for 1 h at 20°C, and reactions terminated 
by addition of 2%  SDS and heated to 95°C. Samples were pro- 
cessed for precipitation with Con A and anti-outer chain antibod- 
ies as described in Materials and Methods. The average of four 
experiments and standard error are indicated. 
Figure 7.  Transport-stimulating activity in the cytosol, prepared 
from ts-mutant cells is sensitive to  a  15  min pre-incubation at 
30°C. Membrane-free cytosol was prepared from the mutant cells 
grown at 24°C as described in Materials and Methods. Portions of 
cytosol were pre-incubated for 15 min either on ice (dark bars) or 
at  30°C  (light bars) and  the  aliquots  (60  Ixg of protein)  were 
added to the transport reaction. Samples were processed as in 
Fig. 5. 
GDP-[3H]mannose  into  the  outer  chains  of endogenous 
yeast  glycoprotein  (data  not  shown).  Because  the  assay 
used in our experiments relied on efficient conversion of the 
[35S]gp-a-factor  contained  in  the  vesicle  fraction  to  the 
al,6-mannose  modified  form,  we  were  unable  to  use 
NEM-treated membranes in our experiments. 
The  transport defect of mutant  cytosols in  half of the 
cases (usol-1, sly1 t~, sec7-4) was rescued by supplementing 
the  reaction with  a  portion of wild-type cytosol (Fig. 8). 
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Figure 6.  Inhibition of targeting/fusion reaction with non-hydro- 
lyzable analogs of GTP and ATP and by chelation of Ca  2+ ions. 
All reaction components were mixed as in Fig. 5 with the addition 
of inhibitors as shown. Samples were processed as described for 
Fig. 5. 
This rescue was inefficient in the case of sec18-1,  sec19-1 
and yptl t" cytosols, probably because of a  "dominant-neg- 
ative" behavior of the mutant protein in the in vitro reaction. 
Fractionation of Soluble Components 
on Mono Q Column 
To resolve the cytosolic requirement for ER-derived vesi- 
cle targeting and fusion, we applied desalted yeast cytosol 
on an FPLC Mono Q  anion exchanger. Protein was eluted 
with a step gradient of 0.9 and 2.0 M  of KOAc, and pooled 
fractions  were  tested  for  transport-stimulating  activity 
(Fig. 9).  No  significant activity was  detected in  the  flow 
Figure 8.  Rescue  of the  heat-inactivated, transport-stimulating 
cytosol activity by wt cytosol. Cytosol was prepared from mutant 
cells, inactivated at  30°C,  and  the  aliquots were  added in  the 
transport  reaction (dark  bars). For some  samples (light bars) 
wild-type cytosol was added to the transport reactions before the 
incubation. Samples were processed as above. Addition of the 
wild-type cytosol (20 Ixg) alone did not support the transport re- 
action (110 cpm after immunoprecipitation with anti-outer chain 
antibodies). 
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fractions. Membrane-free cytosol (20 mg) prepared from Saccha- 
romyces cerevisiae RSY607 cells was dialyzed  against  B88  and 
loaded on a FPLC MonoQ 5/5 column equilibrated  with the same 
buffer. Proteins were eluted by 0.9 M KOAc and then by 2.0 M 
KOAc in B88. The flow through pool (FT), 0.9 M eluate (Q 0.9), 
and 2.0 M eluate (Q 2.0) were collected,  dialyzed  against  B88, 
and  concentrated  to  1 ml using  Centricon-10  (Amicon Corp.) 
concentrators.  Samples  (5 ~l) of each fraction (8-60 Ixg of pro- 
tein) were added to the transport assay in the absence of cytosol. 
Control, no cytosol; cytosol, whole cytosol (60 Ixg protein) added. 
through (unbound) nor in individual eluted fractions when 
assayed  alone,  indicating  that  multiple  components  had 
been separated. When the 0.9 M pool was mixed with the 
2.0 M pool, the activity of whole cytosol was restored, indi- 
cating that the unbound  fraction contained no transport- 
stimulating  activity.  Further  fractionation  of  the  0.9  M 
pool was achieved using an FPLC MonoQ column, eluted 
with  a  KOAc gradient  (Fig.  10 a).  Fractions  were  com- 
bined with the 2.0 M pool and tested for activity in the in 
vitro assay. The highest activity was detected in fractions 
13 (approximately four times background) and fraction 14 
(approximately  two  times  background).  These  fractions 
were pooled and  are  referred to as the  low salt fraction 
(LSF). Fractions (7-25) from the same gradient were ana- 
lyzed for Yptl, Slyl, Sec7, Secl7, Secl8, Sec21, Sec24, and 
Arfl  protein distribution  by immunoblotting (Fig.  10 b). 
Only  two  of these  proteins,  Yptlp  and  Slylp  co-eluted 
with the transport-stimulating activity. Attempts to sepa- 
rate LSF further, by ion-exchange and gel-filtration chro- 
matography yielded no significant activity in any resulting 
fraction when assayed alone or mixed with the 2.0 M pool, 
indicating that either a component was inactivated or mul- 
tiple  components  were  separated  (data  not  shown).  We 
next  examined  the  fractionation  behavior  of  the  2.0  M 
pool. This fraction was reapplied to an FPLC MonoQ col- 
umn, and protein was eluted with a 0.9-2.0 M KOAc gra- 
dient,  and fractions were tested in  our assay (Fig.  11 a). 
When LSF was included in the assay mix one peak of ac- 
tivity (N2.5 times background) was detected, eluting at 1.4 
M  KOAc. We termed this pool high salt fraction (HSF). 
All fractions after the  MonoQ column were analyzed by 
immunoblotting for the same set of proteins as described 
Figure IO.  Mono Q chromatography of LSF activity. Dialyzed 0.9 
M eluate (as in Fig. 9) was loaded on a FPLC Mono Q column 
and fractionated with a 0.15-0.9 M KOAc gradient.  Fractions  (1 
ml)  were  collected,  dialyzed  against  B88, and  assayed in  the 
transport reaction in the presence of 5 ixl of 2.0 M eluate (A); - 
and + cytosols as in Fig. 9. Aliquots  of each fraction were loaded 
on 12.5% SDS-PAGE and various proteins were detected by im- 
munoblotting (B). 
above  (Fig.  11  b).  Sec7p,  Sec18p,  and  Sec21p  were  de- 
tected in the active 2.0 M pool. However only Sec7p com- 
pletely co-eluted with the active fractions. After an addi- 
tional separation of HSF by gel-filtration chromatography 
on an FPLC Superose 6 column only 20%  of the original 
activity was recovered. Again all the transport-stimulating 
activity co-eluted with Sec7p and the peak of activity was 
separated from Secl8p (not shown). The activity peak and 
Sec7p  eluted  as  a  high  molecular weight  (70(0800  kD) 
protein complex. Separation  of the  activity from Sec21p 
and thus yeast coatomer (COP I) was achieved by velocity 
sedimentation in a  glycerol gradient. HSF was loaded on 
the gradient and all activity (~30% from original) co-sedi- 
mented  with  Sec7p  with  a  sedimentation  coefficient  of 
about 10S (data not shown). 
The combination of LSF and HSF supported transport 
in our assay to the same level as whole cytosol indicating 
that all necessary transport-stimulating proteins have been 
recovered. 
The ability of the HSF and the LSF to rescue the activity 
of mutant cytosols was also examined (Fig. 12 a). Addition 
of the HSF to the assay rescued only the defect in sec7-4 
The Journal of Cell Biology, Volume 132, 1996  284 Figure 11.  Mono Q  chromatography of HSF activity. Dialyzed 
2.0 M eluate (as in Fig. 9) was loaded on FPLC Mono Q column 
and fractionated with 0.9-2.0 M KOAc gradient. Fractions (1 ml) 
were collected, dialyzed against B88 and assayed in the transport 
reaction in the presence of 0.9 M eluate (4 tzl) (A); -  and + cyto- 
sols  as in  Fig. 9.  Aliquots of each fraction were separated on 
12.5 % SDS-PAGE and various proteins were detected by immu- 
noblotting (B). 
cytosol, supporting the idea that Sec7p is one of the active 
components of HSF. The HSF, prepared from the sec7-4 
mutant strain was unable to support transport in the pres- 
ence of wt LSF (not shown). Addition of the LSF to the in 
vitro reaction completely rescued the defect in sly1 t~ cyto- 
sol and partially rescued the defect in the cytosol prepared 
from usol-1 mutant cells (Fig. 12 b). Soluble Secl7p (yeast 
a-SNAP),  Secl8p  (yeast NSF),  Sec21p  (a component of 
yeast coatomer [COPI] complex) or Sec24p (a component 
of COPII protein complex) were not required to drive the 
targeting and fusion reactions reconstituted in our in vitro 
assay. Because the membranes used in our assay were not 
salt-treated, a large portion of Secl7p, Secl8p, and Sec21p 
was tightly associated with the Golgi membranes; this pool 
may be sufficient to stimulate the targeting/fusion reaction. 
Sequential Intermediates in the 
Targeting~Fusion Reaction 
We  used  two-stage  incubation  experiments to  study the 
order of involvement of different factors during targeting 
and fusion of ER-derived vesicles with Golgi membranes. 
In the first stage of the reaction membranes were pre-incu- 
bated for 20 min in the presence of 60 Ixg of heat-inacti- 
vated mutant cytosol and an ATP-regeneration system. In 
the second stage, 20 ~g of wt cytosol was added to the re- 
action in  combination with different inhibitors  (Fig.  13). 
This addition of wt cytosol (20  I~g of protein) was suffi- 
cient to support only 25% of targeting and fusion activity 
when  mutant  cytosol  was  omitted  from  the  first  stage. 
When GTP'yS, ATPTS, EGTA, or Yptl Fab were added in 
the  first stage, significant inhibition  of transport was ob- 
served  (Fig.  13,  stage  1).  Similar  results  were  obtained 
when sly1 ts cytosol was present during the first stage of the 
reaction and the different inhibitors were added together 
with wt cytosol during the second stage. The second stage 
of the reaction was not inhibited by GTPTS and Yptl Fab 
when usol-1 or sec7-4 cytosol was present during the first 
stage, but transport reaction remained sensitive to ATPTS 
and EGTA (Fig. 13, stage 2). None of the inhibitors were 
effective at the second stage of the reaction if wt cytosol 
was used at the first stage. 
Fig.  14 summarizes the results of the  inhibitor studies. 
Slylp,  a  GTPTS-sensitive  step  and  Yptlp  (the  function 
likely to be inhibited by GTPTS) may act at an early stage 
in the reaction; Usolp and Sec7p appear to act in a subse- 
quent or a parallel step. The last step is inhibited by ATP'yS, 
probably due to the involvement of the Sec17p and Sec18p. 
We showed previously that a Secl8p-dependent step is fol- 
lowed by a  Ca2+-dependent step in the vesicle-Golgi fu- 
sion  reaction  (Rexach  and  Schekman,  1991).  The  bio- 
chemical  complementation  assay  developed  here  could 
not be exploited to refine this assignment because cytosol 
from yptl t~, and secl8-1  mutant cells were inhibitory in a 
mixed incubation. 
Genetic Interactions of Soluble and Membrane 
Components of the Targeting~Fusion Apparatus 
To corroborate the biochemical data on the involvement 
of  specific  soluble  proteins  in  targeting/fusion  of  ER- 
derived vesicles with Golgi membranes we also tested ge- 
netic  interactions  between  the  genes  encoding  Yptlp, 
Bet2p, Slylp, Usolp, and Sec7p. We crossed pairs of tem- 
perature-sensitive mutants, dissected tetrads from the re- 
suiting diploid strains,  tested  spore growth  at permissive 
(24°C)  and  sub-restrictive  (30°C)  temperatures  and  con- 
firmed our results by complementation analysis in a search 
for synthetic lethal interactions between these mutations. 
When sec7-4 was crossed to yptl ts, the majority of tetrads 
had only three viable spores. This is the expected result if 
the double mutant is inviable. The same results were ob- 
tained with the yptl-3 mutant. When sec7-4 was crossed to 
bet2-1  the double mutant grew at 24°C but, unlike the pa- 
rental  strains,  failed  to  grow  at  30°C.  In contrast,  in  all 
other crosses to sec7-4,  the majority of tetrads had four vi- 
able  spores  at  30°C.  These  data,  together  with  our  bio- 
chemical data on an involvement of Yptlp and Sec7p in 
the  same  process,  support  the  idea  that  the  SEC7  and 
YPT1  gene  products  interact  functionally,  and  possibly 
physically, and suggest that the BET2 gene product may 
also be involved in this interaction. 
YPT1  showed  synthetical  lethal  interactions  not  only 
with SEC7 but also with SLY1 and USO1 (Sapperstein et 
al.,  1996).  In  all  cases  double  mutants  of the  genotype 
yptltSslyl ts and yptltSusol-1 were inviable. We did not de- 
Lupashin et al. ER Vesicle Targeting  and Fusion to Golgi  Membranes  285 Figure 12.  Mutant cytosol rescue by LSF and HSF fractions. Cytosol prepared from mutant cells was heat inactivated (15 rain at 30°C) 
and added to the transport reaction (dark bars). (a) 5 ~1 of LSF pool (Fig. 10, fractions 12-14, 5 mg protein/ml) was added to the reac- 
tion (light bars). (b) 5 pl of HSF pool (Fig. 11, fractions 22-26, 0.9 mg protein/ml) was added to the reaction (light bars). After incuba- 
tion (1 h, 20°C) samples were processed as above. 
tect  any  synthetically lethal  interactions  between  SEC7 
and SLY1 or any of the genes encoding membrane compo- 
nents  of  targeting/fusion  complex  (SEC22,  BET1,  and 
BOS1). 
Discussion 
We  have  purified  functionally  active  yeast  Golgi  mem- 
branes and used them to better define the biochemical re- 
quirements for the targeting and fusion of transport vesi- 
cles  budded  from  the  ER.  Current  biochemical  and 
genetic data suggest that the yeast Golgi complex is orga- 
nized into three distinct functional compartments: cis, con- 
taining cd,6 mannosyltransferases; medial, containing al,2 
and  ed,3  mannosyltransferases;  and  trans,  populated  by 
the late Golgi enzymes Kexlp, Kex2p, and dipeptidylami- 
nopeptidase A  (reviewed by Franzusoff, 1992). The Golgi 
purification procedure was  designed to be rapid because 
we found that transport acceptor activity in crude or puri- 
fied  membranes  decayed  rapidly. The  Golgi  membrane 
fraction purified in this study is operationally defined as an 
early Golgi compartment, and had the highest enrichment 
(600-fold) for the cis-Golgi  membrane  marker, al,6 MT. 
The purified Golgi membrane fraction was also enriched, 
to a lesser degree, for the late Golgi marker, Kex2p (Red- 
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Figure  13.  Two-stage  trans- 
port reaction. Wt or heat in- 
activated (15 min at 30°C) cy- 
tosol  samples  (60  Ixg  of 
protein,  cytosol  1)  were 
added to the transport reac- 
tions  which  were  incubated 
for 20 min at 20°C. Reactions 
were transfered to ice and 2 
p.1  (20  p~g of protein)  of wt 
cytosol was added. Reactions 
were  incubated for an  addi- 
tional 40 min  at 20°C  (stage 
2)  and  samples  were  pro- 
cessed  as  above.  Inhibitors: 
0.2 mM GTP'vS (A), 0.2 Ixg of 
anti Yptlp Fab (B), 2.0 mM 
ATP~,S  (C),  5  mM  EGTA/ 
0.6 mM MnCI2 (D) in 2 p.l of 
B88 were added to the reac- 
tions before the first or sec- 
ond incubations as indicated. 
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Figure 14.  Model for the sequence of involvement of soluble 
components in the targeting/fusion reaction. 
ding et al., 1991), but was depleted for marker proteins of 
the ER,  plasma membrane, the vacuole, and mitochon- 
dria. Membranes were free of the ER peripheral proteins 
Secl3p  and  Sec24p.  Two  peripheral  proteins,  the  small 
GTP-binding protein, Yptlp, and the yeast a-SNAP ho- 
molog, Sec17p,  were  significantly enriched in the  Golgi 
fraction. We  also found that Sed5p,  Sec7p,  Sec18p,  and 
yeast coatomer co-purified with cis-Golgi membranes, but 
to a lesser extent than Yptlp and Secl7p. After treatment 
of isolated membranes with high salt (1 M KOAc) some 
peripheral proteins  (Secl7p, Secl8p, coatomer) were re- 
moved whereas the majority of Yptlp and Sec7p remained 
tightly associated with the Golgi membranes (Fig. 4 d and 
data not shown).  Analysis of untreated  and salt-treated 
purified membranes by thin-section electron microscopy 
revealed that the purified Golgi consists mainly of a mixed 
population of vesicular and tubular  membranes ranging 
from 50 to 300 nm in diameter and length. About 40% of 
these structures were densely labeled with antibodies to 
Yptlp on thin sections prepared for immunoelectron mi- 
croscopy. These results are similar to immunoelectron mi- 
croscopic observations by Preuss et al. (1992),  who found 
morphologically similar structures labeled with anti-Yptlp 
IgG and anti a-l,6-mannose antibodies in wild type yeast 
cells. 
We found that vesicle targeting and fusion with the puri- 
fied Golgi membranes required ATP, GTP, Ca  2÷, and cy- 
tosol.  Nonhydrolyzable nucleotide  analogs  ATP'yS  and 
GTP'yS specifically blocked vesicle consumption in the re- 
constituted in vitro reaction. The primary target for the 
GTP~/S inhibition is most probably the Yptl protein. No- 
vick and Brennwald (1993)  proposed that Yptlp can load 
on the surface of the transport vesicles in the GTP-bound 
form and be released to the cytoplasm in the GDP-bound 
form by the action of GDI (guanine nucleotide dissocia- 
tion inhibitor).  Thus  GTP  hydrolysis appears  to  be  re- 
quired for the proper function and recycling of Yptlp. It is 
notable that GTP hydrolysis is required at least twice dur- 
ing one round of ER to Golgi transport, first for transport 
vesicle uncoating mediated by Sarlp (Barlowe et al., 1994) 
and later during the targeting/fusion step, probably for the 
formation of the targeting complex (S611ner et al.,  1993; 
S0gaard  et  al.,  1994) involving Yptlp.  ATP  hydrolysis, 
which  is  inhibited  by ATP~/S,  is  probably  required  for 
Secl8p function during the maturation of a targeting com- 
plex (Wilson et al., 1992; Rothman, 1994). In the presence 
of ATP~S a  specific 20S  complex can form in vitro in a 
mammalian transport assay (S611ner et al., 1993). The 20S 
particle contains SNAREs, SNAP-25, NSF, and a-SNAP 
and is disassembled when ATP is hydrolyzed (Wilson et 
al., 1992). 
Specific protein requirements for ER-derived transport 
vesicle  targeting  and  fusion  with  cis-Golgi  membranes 
were revealed by inhibition of Sec protein function in mu- 
tant  cells.  Cytosol prepared  from  temperature-sensitive 
mutant cells was inactivated by brief incubation at an ele- 
vated temperature; in some cases transport  activity was 
rescued by the addition of a small amount (20 txg) of wild 
type cytosol. These studies showed that Sec7p, a periph- 
eral membrane protein (Achstetter et al., 1988), Yptlp, a 
peripheral  and cytosolic GTP-binding protein  (Segev et 
al., 1988), Secl9p, a cytosolic protein (Garrett et al., 1994), 
Slylp,  a  peripheral  membrane  protein  (Dascher  et  al., 
1991),  Usolp, a peripheral membrane protein (Nakajima 
et al.,  1994; Seog et al., 1994), and Secl8p, yeast NSF ho- 
molog (Eakle et al., 1988) are required for vesicle target- 
ing and fusion. 
Most of the targeting Sec proteins are highly enriched in 
the transport stimulating fractions purified from yeast cy- 
tosol on the FPLC MonoQ column. We found that the cy- 
tosolic requirement for the transport reaction was satisfied 
by a mixture of two protein fractions eluted from FPLC 
MonoQ  columns;  one  at  low  (0.2--0.3  M  KOAc)  salt, 
termed LSF, and one eluted in high (1.4  M  KOAc) salt, 
termed HSF. LSF is enriched for Yptlp and Slylp. Soluble 
Secl7p was not required to drive the transport reaction in 
vitro, but like Secl8p, the bulk of Secl7p was found al- 
ready associated with Golgi membranes. The most likely 
active components of LSF are Yptlp and Slylp. It is possi- 
ble that this fraction also contains Secl9p. We found that 
the LSF, but not HSF, prepared from sec19-1 cytosol was 
defective in our transport assay (data not shown). Addi- 
tion of wild type LSF to the transport  reaction rescued 
slyU and usol-1 mutant cytosols. We could not determine 
the fractionation properties of Sec19p or Usolp due to the 
lack of specific antibodies. The precise biochemical func- 
tion of Usolp or its mammalian homolog pl15  (Sapper- 
stein et al.,  1996) is currently unknown, pl15 is required 
for  the  docking or  fusion  step  in  intra-Golgi  transport 
(Waters et al., 1992) and for binding of transcytotic vesi- 
cles to plasma membrane (Barroso et al., 1995). Usol is re- 
quired for the assembly of the ER to Golgi SNARE com- 
plex (Sapperstein et al., 1996). 
HSF was enriched for Sec7p, and also contained some 
coatomer complex and Secl8p. Additional purification of 
HSF by gel-filtration and glycerol velocity sedimentation 
revealed that the activity co-purified only with Sec7p and 
that  coatomer  and  Secl8p  were  not  functional compo- 
nents of HSF activity. 
The main candidate for the active component of HSF is 
Sec7  protein  (and  possibly  Sec7p-associated  proteins). 
Sec7 immunoreactive material co-purified with HSF activ- 
ity on every ion-exchange and gel-filtration column used, 
as well as on a glycerol velocity gradient. It appears that 
Sec7p forms a complex with several other proteins (Fran- 
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could be time and condition sensitive. Cytosol prepared 
from see7-4 mutant cells was defective in the transport assay, 
and its activity was restored by addition of HSF prepared 
from wt cytosol. ER to Golgi transport of [35S]gp-a-factor 
in the see7-4 or sec7-1 semi-intact cells was temperature- 
sensitive. At the restrictive temperature accumulation of 
core-glycosylated pro-a-factor in a functional vesicle inter- 
mediate was observed (data not shown). 
Franzusoff et  al.  (1992)  observed  accumulation  of  a 
transport  vesicle intermediate  as  a  result  of an  ER  to 
Golgi transport block in vitro induced by addition of anti- 
Sec7p IgG, which affects cytosolic, but not Golgi-associated 
Sec7p. These authors proposed a role for Sec7p as a coat 
protein. However, the Sec7p is not required to form ER- 
derived transport vesicles (Barlowe et al.,  1994),  and in- 
stead it is mainly found associated with the Golgi mem- 
brane surface (Preuss et al., 1992; and data not shown). It 
is possible that Sec7p (and probably other proteins, like 
Usolp  and Yptlp)  binds to the  surface of the transport 
vesicles in exchange for the COPII-type protein coat just 
before targeting to the acceptor membrane. Such re-coat- 
ing could be required to facilitate correct targeting of the 
vesicles to the acceptor membrane. If this model is correct 
then it may be possible to reconstitute such a reaction us- 
ing purified ER-derived transport vesicles. 
Alternatively, Sec7p,  and  probably Yptlp  and  Usolp 
bind to the cis-Golgi membrane surface prior the vesicle 
targeting  and  are  required for the  docking of uncoated 
transport vesicles. If this model is correct, then previously 
described immuno-purified membranes enriched for Sec7p 
(Franzusoff et al.,  1992)  and/or Yptlp  (Lian and Ferro- 
Novick, 1993) were not the ER-derived transport vesicles 
but rather Golgi fragments. 
Surprisingly, soluble  Secl8p  and  Secl7p were not  re- 
quired for our in vitro targeting/fusion reaction, although a 
similar activity (NSF and a-SNAP) is required in the re- 
constituted mammalian intra-Golgi transport reaction (Wil- 
son et al., 1989; Clary et al., 1990). In the mammalian system 
this requirement was revealed only when the membrane- 
bound Sec18p-like protein, NSF, was inactivated by NEM 
treatment or after salt extraction of the membranes. The 
significant amounts of Sec17p and Sec18p tightly associ- 
ated with  our purified Golgi membranes were probably 
sufficient to provide this essential activity during the tar- 
geting/fusion reaction. Salt extraction, which removed ap- 
proximately 80%  of the  membrane  bound  Sec17p  and 
Sec18p  from  our  enriched  Golgi  membranes  (data  not 
shown),  may  be  sufficient  to  reveal  a  requirement  for 
these and other peripheral proteins in our targeting/fusion 
reaction. 
We used two-step transport reactions to study the bio- 
chemical sequence of involvement of different soluble ac- 
tivities in the targeting/fusion reaction. Slylp, Yptlp, and 
GTP hydrolysis are required during the early stages of the 
reaction. Sec7p and Usolp are involved in a parallel or in 
a later step possibly after Yptlp has already been loaded 
with GTP. We suggest that all these proteins are recruited 
to the surface of uncoated ER-derived vesicles as a pre- 
lude to recognition of the acceptor membrane and forma- 
tion of a pre-fusion complex. The biochemical complemen- 
tation assay described here allows a functional reconstruction 
of this targeting process with enriched cytosolic proteins. 
Further effort is required to achieve a fully resolved sys- 
tem. 
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